"Methods Of Administering Solriamfetol To Lactating Women" in Patent Application Approval Process (USPTO 20240350435).

The patent application by inventor Herriot Tabuteau focuses on methods of administering solriamfetol to lactating women to reduce potential adverse events in infants fed breast milk from treated subjects. The invention involves orally administering solriamfetol at specific doses and timing to minimize exposure and adverse effects in infants. The methods aim to treat disorders such as narcolepsy, excessive daytime sleepiness, obstructive sleep apnea, attention deficit hyperactivity disorder, cognitive impairment, or binge eating disorder in lactating women while safeguarding infant health. [Extracted from the article]